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Abstract
Ovarian cancer remains the most frequently lethal of the gynecologic cancers owing to the late detection of this
disease. Here, by using human specimens and three mouse models of ovarian cancer, we tested the feasibility of
nonlinear imaging approaches, the multiphoton microscopy (MPM) and second harmonic generation (SHG) to
serve as complementary tools for ovarian cancer diagnosis. We demonstrate that MPM/SHG of intrinsic tissue
emissions allows visualization of unfixed, unsectioned, and unstained tissues at a resolution comparable to that
of routinely processed histologic sections. In addition to permitting discrimination between normal and neoplastic
tissues according to pathological criteria, the method facilitates morphometric assessment of specimens and de-
tection of very early cellular changes in the ovarian surface epithelium. A red shift in cellular intrinsic fluorescence
and collagen structural alterations have been identified as additional cancer-associated changes that are indiscern-
ible by conventional pathologic techniques. Importantly, the feasibility of in vivo laparoscopic MPM/SHG is dem-
onstrated by using a “stick” objective lens. Intravital detection of neoplastic lesions has been further facilitated
by low-magnification identification of an indicator for cathepsin activity followed by MPM laparoscopic imaging.
Taken together, these results demonstrate that MPM may be translatable to clinical settings as an endoscopic
approach suitable for high-resolution optical biopsies as well as a pathology tool for rapid initial assessment of
ovarian cancer samples.
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Introduction
Ovarian cancer is the deadliest gynecologic cancer and the fifth leading
cancer in cancer-related deaths in women in the United States. It will be
responsible for approximately 21,550 (3% of total) of new cancer cases
and 14,600 (5% of total) of cancer-related deaths in 2009 [1]. When
the disease is diagnosed at its early stages, the survival rate can be higher
than 90%. However, because the early stages are relatively asymp-
tomatic, most cases of ovarian carcinomas are not identified until late,
rarely curable stages when almost 70% of tumors have already spread
beyond the ovary [2]. Cytoreductive surgery of metastatic ovarian
cancer may extend the patient’s survival, but its success greatly depends
on effective detection and elimination of the bulk of tumor [3–5].
Development of new imaging diagnostic approaches is expected
to significantly advance detection of ovarian cancer. Several recent
studies have reported on improved detection of metastatic ovarian
cancer by multitargeted in vivo optical imaging [6] and fluorescence
protease imaging in immunocompromised mice [7]. Unfortunately,
Address all correspondence to: Alexander Yu. Nikitin, Department of Biomedical
Sciences, Cornell University, T2 014A VRT Campus Rd, Ithaca, NY 14853-6401.
E-mail: an58@cornell.edu; or Warren R. Zipfel, Department of Biomedical Engineering,
B45 Weill Hall, Cornell University, Ithaca, NY 14853. E-mail: wrz2@cornell.edu
1This work was supported by National Institutes of Health grants CA112354, CA96823,
and RR17595 (to A.Y.N.); CA116583 and P41-RR04224 (to R.M.W. andW.R.Z.); and
P50 CA083638 (to D.C.C., T.C.H., and A.Y.N.).
2These authors contributed equally.
Received 9 October 2009; Revised 22 December 2009; Accepted 29 December 2009
Copyright © 2010 Neoplasia Press, Inc. All rights reserved 1944-7124/10/$25.00
DOI 10.1593/tlo.09310
www.transonc.com
Trans la t iona l Onco logy Volume 3 Number 3 June 2010 pp. 181–194 181
resolution of these approaches has precluded evaluation of neoplasms
at the cellular level. Furthermore, feasibility of intravital detection of
earlier stages of ovarian cancer has not been demonstrated.
A possible approach to address both issues is nonlinear imaging by
multiphoton microscopy (MPM) and second harmonic generation
(SHG). MPM is a type of incoherent nonlinear laser scanning micros-
copy that uses the simultaneous absorption of two near-infrared (NIR)
photons to excite an electronic transition equivalent to the absorption
of a single higher energy, “bluer” photon [8,9]. Use of (NIR) light in-
stead of UV or higher energetic bands, which are required to excite
most intrinsic emitters in biological tissues [10–12], mitigates UV-
associated photodamage, optical aberrations, and excitation light at-
tenuation. These advantages, together with absence of out-of-focal
plane excitation, allow MPM to penetrate approximately two-fold
deeper into optically scattering tissues with much cleaner subcellularly
resolved images compared with confocal microscopy (see reviews by
Zipfel et al. [9] and Helmchen and Denk [13]). MPM is frequently
used simultaneously with SHG, an imaging strategy based on non-
linear coherent scattering of the illumination light by asymmetricmacro-
molecular tissue components, such as collagen. SHG always emits at
exactly one-half of the illumination wavelength and is easily separated
from the broad generally blue fluorescence emission spectra character-
istic of unstained tissue, enabling simultaneous imaging of collagen at
the single fibril level [12].
Owing toMPM’s features, such as depth of penetration, reduced photo-
toxicity, and intrinsic optical sectioning, and SHG’s high-resolution
assessment of fibrillar collagen structure not visible in standard hema-
toxylin and eosin (H&E)–stained sections, these nonlinear imaging
methods have been recognized as promising approaches for cancer di-
agnostics [12]. Optical biomarkers of ovarian cancer were specifically
evaluated with nonlinear microscopy [14]. However, it remains unclear
to what extent MPM/SHG imaging will allow for robust identifica-
tion of routine diagnostic pathological features. Furthermore, the appli-
cability of MPM/SHG to characterization of various stages of ovarian
carcinogenesis in autochthonous mouse models of cancer has not been
tested. Most importantly, it is unknown whether there is adequate sen-
sitivity to identify features in vivo, making the feasibility of practical
high-resolution endoscopic MPM/SHG uncertain.
In this article, we assess of applicability of the MPM/SHG approach
to pathological evaluation of epithelial ovarian carcinoma (EOC) in
human samples and three syngeneic mouse models generated by us.
We demonstrate that MPM of intrinsic tissue fluorescence in ovarian
tissues allows reproducible identification of neoplastic features such
as cellular atypia and architectural alterations at different stages of car-
cinogenesis. This information is further complemented by MPM/
SHG–specific features such as cancer-associated alterations in intrinsic
fluorescence and collagen structure. Finally, we demonstrate, in a
proof-of-principle experiment, that high-resolution MPM/SHG opti-
cal biopsy can be accomplished by in vivo laparoscopy with a miniature
stick objective lens. This approach can be further combined with pre-
screening for neoplastic changes by a cathepsin-activated NIR fluores-
cent probe.
Materials and Methods
Mouse Models of Ovarian Cancer
Development of EOC in mice expressing Simian virus (SV) 40 T
antigen under control of the Mullerian inhibitory substance receptor
2 promoter (TgMISIIR-TAg) was described previously [15].
Induction of EOC by a single transinfundibular intrabursal ad-
ministration of recombinant adenovirus-expressing Cre (AdCre) in
mice carrying floxed copies of p53 and Rb genes was also described
elsewhere [16].
To prepare a syngeneic mouse model of disseminated peritoneal
EOC- a p53-, and Rb-deficient FVB/N ovarian surface epithelium
(OSE) cell line OSN1 [17] was transduced with LNCX2 retrovirus
containing mouse c-Myc (kind gift fromDr Andrew Yen). Briefly, retro-
virus was produced by EcoPack2-293 (protocol PT3132-1; Clontech
Laboratories, Palo Alto, CA), and exponentially growing cells were ex-
posed to a medium containing 50% retroviral supernatant and 8 μg/ml
polybrene (S2667; Sigma, St. Louis, MO) for 24 hours. The medium
was changed for complete growth medium, and 500 μg/ml G418 (gen-
tamicin sulfate; Cellgro, Sigma) was added 48 hours afterward. The
resulting cell line OSN3 was intraperitoneally inoculated into 5- to
6-week-old FVB/N inbred mice (Taconic, Hudson, NY) at a concen-
tration of 1 × 107 cells/0.5 ml of PBS. Mice injected with 0.5 ml of
PBS only were used for control.
At scheduled time points or on signs of illness, the animals were
either anesthetized or killed, and their tissues were processed for
in vivo or ex vivo imaging, respectively, followed by histologic process-
ing and pathological assessment as described later. As a control for
morphologic alterations during imaging, a part of some specimens
was directly processed for histologic analysis. In addition, a parallel
identically treated group of animals was killed at the same time
points and subjected to standard necropsy and processing procedures.
All mice were maintained identically following recommendations of
the Institutional Laboratory Animal Use and Care Committee.
Cell Culture
Preparations of primary normal and p53/Rb mutant OSE cells
were performed as previously described [16–18]. Briefly, OSE cells
were isolated by collagenase-dispase digestions of ovaries from mice
carrying floxed copies of p53 and Rb genes [16]. Cells were expanded
within three passages, exposed to AdCre, and used after three pas-
sages. Complete Cre-LoxP–mediated gene excision was verified by
polymerase chain reaction [16]. For control experiments, OSE cells
were exposed to adenovirus-expressing β-galactosidase (AdLacZ).
Human Materials
Using anonymous fresh surgical material tagged for disposal, speci-
mens of morphologically normal ovaries and serous EOC were col-
lected at the Weill Medical College of Cornell University. One- to
three-millimeter-thick slices of the material were prepared, immedi-
ately placed into either Ringer’s solution or serum- and phenol red–
free, HEPES-buffered RPMI and kept on ice. The material was
transported to imaging facilities and used for collection of images
by multiphoton microscope within 6 to 20 hours after resection.
All procedures were approved by the institutional review board.
Nonlinear (MPM and SHG) Imaging of Intrinsic Fluorescence
Multiphoton imaging was accomplished as previously described
[12,19,20]. Briefly, a 780-nm uncompensated beam from a mode-
locked Ti:sapphire laser (Tsunami pumped with a Millennia Xs;
Spectra Physics, Mountain View, CA) was directed through a Pockels
Cell (350-80LA; Conoptics, Danbury, CT) with laboratory-built elec-
tronics for beam modulation and blanking during scan fly-back. The
beam was then directed into a modified BioRad scanner (MRC-600,
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Hercules, CA) interfaced with a modified (fixed stage) Olympus AX-
70 upright microscope (Center Valley, PA). Specimens were imaged
either with a standard objective (20×/0.95W XLUNPlanFl; Olympus)
or with an endoscopic stick objective (27×/0.7W IV-OB35F22W20;
Olympus). Tissue emissions were separated from the excitation beam
using a 670DCXRU long-pass dichroic filter (Chroma Technology,
Inc, Rockingham, VT) placed directly at the back aperture of the mi-
croscope objective. The emissions were subsequently separated into
two channels with a 440DCXRU long-pass dichroic and HQ390/
702-2P and BGG22 emission filters (Chroma Technology, Inc). The
first channel (355-425 nm, pseudocolored blue in the figures) is de-
signed for collecting second harmonic from fibrillar collagen and the
second channel (∼450-550 nm, pseudocolored yellow) collects emis-
sions from tissue intrinsic fluorescence such as cellular NAD(P)H and
retinoid compounds. Both signals were detected using blue bialkali-
photocathode PMT assemblies (HC125-02; Hamamatsu, Bridgewater,
NJ). For determining intrinsic fluorescence color—long-wavelength
(LW) versus short-wavelength (SW) emission—signals were instead sep-
arated using a 500DCXRU dichroic splitter to BGG22 (SW) and
580DF150MP (LW) emission filters (Chroma Technology, Inc). All
imaging on freshly excised mouse samples occurred within 15 minutes
after removal.
Analysis of collagen fibril alignment in the peritoneum was ana-
lyzed by calculating two-dimensional fast Fourier transforms (FFTs)
of high-resolution SHG image stacks (164 × 110 × 10 μm3). The
resulting Fourier images were fit to two-dimensional Gaussian sur-
faces, and their asymmetry was defined as the ratio of major to minor
axes. Image stacks were collected from the peritoneum around tumors
of two EOC mice (n = 4 stacks) and in two control mice (n =
4 stacks).
Quantitative Assessment of Intrinsic Fluorescence: Intensity,
Color, and Anisotropy
For quantification of intensity, color, and steady-state emission
anisotropy of the intrinsic fluorescence in cell cultures, cell regions
were automatically defined by pixel intensities greater than the mea-
sured image background plus the image SD. In tissue explants, cells
of interest were masked manually using the paint tool and an ad-
ditional channel in Adobe Photoshop (San Jose, CA). All pixel tab-
ulation routines were custom-written using the IDL data analysis
environment (ITT Visual Information Solutions, White Plains, NY).
For anisotropy measurements, the excitation polarization was
adjusted for linear polarization (∼50/1 ellipticity) directly after the
objective by means of a Berek compensator (5540; New Focus,
San Jose, CA) placed before the scanning box. The emitted fluores-
cence was separated into parallel and perpendicular components after
the collecting objective with a broadband polarizing beam splitter
(10FC16PB.3; Newport, Irvine, CA) and two polarizers (5511;
New Focus) placed immediately before the emission filters (BGG22;
Chroma Technology, Inc). The fluorescence anisotropy A was defined
as the normalized difference between the emission intensities parallel
(I∥) and perpendicular (I⊥) to the exciting polarization:
A =
I∥ − I⊥
I∥ + 2I⊥
Calibration of the relative detected efficiencies (I ∥′ and I⊥′) was ac-
complished by rotating the excitation polarization so that the parallel
channel became the perpendicular channel and vice versa. For an iso-
tropic sample, the measured anisotropy is the same with both excita-
tion polarizations so that:
A =
I∥′ − gI⊥′
I∥′ + 2I⊥′
= Arot =
I∥rot′ − ð1= gÞI⊥rot′
I∥rot′ + 2I⊥rot′
This relationship was used to determine g, the relative scaling factor
between the two channels accounting for differential emission path ef-
ficiencies, and PMT gain variations. Average anisotropy values for the
masked regions were calculated by an algorithm written within IDL.
Quantification of red shift in cellular intrinsic fluorescence of tis-
sues was accomplished by masking normal OSE or tumor regions in
images from the disseminated metastasis mouse model. Average pixel
values from the LW versus SW channels from those regions were tab-
ulated using a custom-written algorithm within IDL.
In Vivo Imaging
The mouse to be imaged was shaved and anesthetized in an induc-
tion chamber with 3.5% isoflurane gas. After 1 to 2 minutes, it was
transferred to the imaging stage where gas was delivered through a
0.5-inch-diameter tube with a small opening to insert the mouse
snout, and warming was accomplished with a heating pad with feed-
back from a rectally inserted probe monitoring core temperature (FHC
model 40-90-8C A720D). Gas percentage was adjusted to 1% to
2%, maintaining a ∼60/min breathing rate as described previously
[21]. For imaging with a standard water immersion objective (Olym-
pus XLUNPlanFl 20×/0.95 W), a Parafilm bed was suspended over
the mouse as a platform to isolate the ovary from mouse breathing
motions. The ovary was threaded through an incision in the abdomen
and a precut opening in the suspended Parafilm bed. Immersion sa-
line necessary for optimal imaging was kept around the ovary by the
Parafilm bed.
Imaging directly into the mouse abdomen was accomplished using
the 3.2-mm-diameter Olympus stick objective lens (IV-OB35F22W20
27×/0.7 W). In addition to the microprobe optic, two other devel-
opments were required for obtaining high-quality cellularly resolved
tumor images within the abdominal cavity: 1) a mechanism for flush-
ing blood and other optically unfavorable, tissue-derived substances
away from the imaging region, and 2) a mechanism for stabilizing
the tissues from mouse movements. We initially designed a sleeve
through which the microprobe slid for focusing; the sleeve was con-
nected to perfusion piping and provided stabilization to the tissue. This
design turned out to be too bulky and drew the tissue into it when
the probe was moved away from the specimen. A simpler design in
which a small tube (2 mm in diameter) was mounted on a separate
micromanipulator proved better for flushing tissues in the field of
view. The hose also acted to stabilize the tissue, reducing tissue motion
due to mouse breathing and objective focusing.
Imaging of Cathepsin Activity
For administering ProSense 680 (VisEnMedical, Inc,Woburn,MA),
mice were anesthetized with Avertin (2.5% vol./vol. in 0.85% NaCl;
0.020 ml/g body weight), and the ProSense 680 was injected into a
tail vein at 2 nmol/150 μl in PBS. Mouse tissues were imaged ex vivo
24 hours after ProSense 680 administration. Overall fluorescence
images were collected using the RFP2 filter on an Olympus SZX12
fluorescence stereomicroscope. Multiphoton imaging of ProSense 680
was accomplished as previously described for intrinsic fluorescence,
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except that the fluorescence emission was instead split by a 560DCXRU
into blue- (BGG22; ChromaTechnology, Inc) and red- (650DF100MP;
Chroma Technology, Inc) pseudocolored channels. The blue emis-
sion was detected with a bialkali PMT (HC125-02; Hamamatsu) and
the NIR ProSense 680 emission (pseudocolored red in the figures)
was detected using a red-sensitive GaAsP photocathode PMT (H7422P-
40; Hamamatsu) with custom-designed amplifier circuitry. ProSense
680 imaging required significantly (typically fivefold) less excitation
power than that for imaging intrinsic fluorescence.
Pathological Assessment
Human and mouse specimens were labeled by ink for orientation,
placed into PBS-buffered 4% paraformaldehyde, fixed overnight, and
processed for paraffin embedding. Before sectioning, samples were
carefully oriented to ensure direct comparison of MPM/SHG and
routine microscopic images. Prepared sections were stained with
H&E and evaluated under a light microscope. All ovarian lesions
were identified according to the Classification Guidelines endorsed
by the Mouse Models of Human Cancer Consortium [22,23] and
World Health Organization’s classification of human ovarian cancer
[24]. Histologic images were collected by SPOT-RT or Insight cam-
eras (Diagnostic Instruments, Sterling Heights, MI) and compared
with MPM/SHG images of the same or parallel specimens.
Morphometric Analysis
Digital MPM images of z series with 5-μm steps were imported
into SPOT software (v. 4.6; Diagnostic Instruments). Comparable
areas of optical sections across OSE covering the corpus luteum were
identified, and nuclear and cytoplasmic contours were manually
marked by individuals who were blinded to the experimental param-
eters. Image overlays were recorded and parameters calculated using
the measurements function.
Statistical Analysis
For statistical analysis, two-sided unpaired Student’s t tests were
performed using InStat 3.05 and Prism 4.03 software (GraphPad,
Inc, La Jolla, CA).
Results
High-Resolution Multiphoton Microscopy of Intrinsic
Fluorescence in Mouse and Human Ovarian Cancer
Previously, we demonstrated that histologic architecture of the
normal ovary and its cellular composition can be accurately identified
by MPM of intrinsic fluorescence of freshly excised samples [12].
Therefore, to determine the value of MPM for pathological assess-
ments of neoplastic lesions, we compared images taken with MPM/
SHG without added fluorescent labels with those from sections after
routine histologic processing and H&E staining of the normal OSE
and its neoplasms (both mouse and human). As visualized using
H&E staining, normal OSE presented as a single layer with squa-
mous morphology (Figure 1A). In contrast, ovarian carcinomas of
TgMISIIR-TAg mice (n = 12) contained densely packed polygonal
atypical epithelial cells (Figure 1D). In agreement with our previously
reported observations [15], the neoplastic cells were arranged in solid
sheets and separated by a limited stroma. MPM/SHG imaging of fresh
unstained tissues provided the same level of resolution in terms of
the overall histologic and cellular features of the normal (Figure 1, B
and C) and neoplastic tissues (Figure 1, E and F ). Similar to H&E
staining, neoplastic features, such as high nuclear-cytoplasmic ratios,
variations in cell sizes and altered tissue architecture were easily iden-
tifiable. MPM/SHG imaging also allowed better visualization of col-
lagenous stroma (Figure 1, B, C , E , and F ) and demonstrated that
most collagen fibers near the invasive edge are located perpendicular
toward its surface (Figure 1, E and F ). At the same time, H&E sec-
tions were essential for evaluation of key pathological characteristics
such as nucleoli, chromatin condensation, and overall tinctorial prop-
erties of tissues. Identification of mitotic and apoptotic cells was also
problematic with MPM/SHG alone.
To extend the generality of these observations, we developed and
evaluated a new model of disseminated peritoneal EOC. In this model,
OSE transformed by p53 and Rb inactivation and c-Myc overexpres-
sion form multiple neoplastic tumors on the visceral and parietal walls
of the abdominal cavity 3 to 5 weeks after intraperitoneal injection.
Similar to neoplasms of TgMISIIR-TAg mice, neoplastic cells were
identified by both H&E and MPM/SHG imaging (Figure 1, G and
H ) in all 10 studied cases. Notably, these tumors also had an aberrant
appearance and orientation of collagen (Figure 1, H and I ). Fibrils
underlying normal peritoneal mesothelium were relatively uniform
and had a wavy appearance, whereas those around tumor masses
had variable diameter and a straight-rigid appearance. Uniformity
and appearance aberrations were well discernable (at low and high res-
olutions, respectively) by projecting optical slices from a collagen im-
age stack underlying mesothelium (Figure 1, J and K ) or neoplastic
cells (Figure 1, L and M ). Alignment properties were automatically
analyzed by computing FFTs of the projected images and fitting
Gaussian ellipses to the resulting Fourier components. FFTs from nor-
mal (Figure 1N ) and carcinomatous (Figure 1O) peritoneum image
stacks revealed a significant increase in asymmetry (P = .0456) of
the tumor fibrils with respect to normal fibrils (mean ± SE; 3.0 ±
0.6, n = 4 vs 1.49 ± 0.02, n = 4). A potential difference in segmental
collagen indicative of fibrillogenesis (observable as micrometer-scale
spots in the images, see Williams et al. [25]) was also investigated. Col-
lagen segments were hypothesized to be more numerous in the cancer
tissues owing to an increased collagen turnover in these tissues (see,
e.g., Kenny and Lengyel [26]). However, the amount of observable
segmental collagen was found to be fairly equivalent in the cancer
and control tissues.
We next tested the application of MPM/SHG to human samples.
Comparative analysis of normal ovary (Figure 2, A and B, n = 8) and
ovarian adenocarcinomas (Figure 2, C and D, n = 4) confirmed that
this approach provides a level of detail similar to that obtained with
standard histologic processing, with previously noted advantages and
limitations. Consistent with observations in mouse models and stud-
ies in human tissues [14], collagen from human EOC tumors was
generally observed in thicker, less uniform bands than that from nor-
mal ovaries (Figure 2, D vs B).
MPM-Based Morphometric Analysis Allows Detection of Early
Changes during Ovarian Carcinogenesis
According to literature reports, in humans, early ovarian lesions can
be identified according to their morphometric parameters, such as en-
larged cellular and nuclear size [27–31]. However, because identifica-
tion of such lesions is usually accompanied by ovariectomy, their
progression to carcinoma remains unconfirmed. To reproducibly ex-
amine early events associated with ovarian carcinogenesis, we turned
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Figure 1. Evaluation of MPM (yellow) and SHG (blue and grayscale) potential for examination of mouse EOC. Normal mouse ovary (A–C),
ovarian carcinomas of TgMISIIR-TAg (D–F), and disseminated peritoneal EOC (G–M) mouse models were visualized by H&E staining
(A, D, and G). MPM intrinsic emission (B, E, and H) and SHG imaging (B, C, E, F, H, I–M). (A–C) The ovarian surface epithelium
(OSE, arrow), part of the corpus luteum (CL), and the ovarian bursa (OB) are all clearly resolvable by MPM and resemble those in con-
ventional histologic image. In addition, SHG demonstrates collagen in the ovarian bursa and the basement membrane (BM) underneath
of OSE. (D–F) Monomorphous polygonal neoplastic cells (arrow) are detectable by H&E and MPM. Note that SHG demonstrates pres-
ence of collagen with most collagen fibers near tumor periphery being located perpendicular toward its surface (arrowhead), a feature
not evident in conventionally prepared tissue. (G–H) A group of neoplastic cells (arrow) invading the parietal peritoneum. Low- (J and L)
and high- (K and M) magnification projection images of collagen architecture from normal peritoneum (J and K) and around tumor re-
gions (L and M). (N and O) Representative Fourier transforms from the full images shown in K and M, respectively. Gaussian ellipses
(blue) are fit to determine the collagen fibril asymmetry. MPM images were acquired using 780-nm excitation. Blue and yellow pseudo-
colors represent 355 to 425 nm and 450 to 550 nm emissions, respectively. For clarity, the SHG images are reproduced in gray in C, F,
and I to M. Scale bars: 30 μm (A–C), 22 μm (D–F), 45 μm (G–I, J, and L), and 12 μm (K and M).
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to our model of serous ovarian adenocarcinoma initiated by condi-
tional inactivation of OSE p53 and Rb after a single transinfundibular
intrabursal injection of AdCre [16]. This model is uniquely suited for
such studies because of temporal and local control of the initiating
event. EOC develop relatively synchronously and lead to death in
97% of mice with median survival of 227 days after gene inactiva-
tion [16].
Similar to other ovarian samples, neoplastic lesions discernable by
pathological evaluation of H&E sections were readily detectable by
MPM/SHG (Figure 3, A and B). Furthermore, MPM/SHG allowed
detection of a thickening of the collagen fibers at or near the basement
membrane underlying early dysplastic lesions (compare Figure 3, C
and D, with Figure 1, B and C). After confirming our earlier obser-
vations that more than 90% of OSE cells are infected after adminis-
tration of 5 × 107 pfu/μl of adenovirus (Figure 3E and Flesken-Nikitin
et al. [16]), we next tested whether MPM/SHG optical sectioning
could facilitate detection of morphologic alterations at 8 and 34 days
after conditional inactivation of p53 and Rb. No changes in cellular
morphology and histologic architecture were detected by visual eval-
uation of either H&E or MPM sections. However, a quantitative
morphometric assessment of MPM sections taken in parallel to the
ovarian surface demonstrated a significant enlargement of nuclei and
cytoplasm of OSE 8 and 34 days after initiation of carcinogenesis (Fig-
ure 3, F–H ). Interestingly, nuclear-cytoplasmic ratios were not changed
to any significant extent (P = .6547 and P = .3761 at days 8 and
34, respectively).
Quantitative Changes in Intrinsic Fluorescence Properties of
Ovarian Cancers
Because the intracellular fluorescence signal in epithelial cells is
thought to derive primarily from NAD(P)H, we hypothesized that
characteristics of this signal—intensity, spectrum, or anisotropy—
may yield further information about the metabolic state of cells. We
initially tested these parameters in primary OSE cells carrying floxed
p53 and Rb genes three passages after exposure to AdCre or AdLacZ
(control). Indeed, intensity in cells with p53/Rb deletion was signifi-
cantly lower (60 ± 4%, mean ± SE, n = 32 images) than that of the
normal population (100 ± 12, n = 16 images, P = .0003). We also
observed a slight spectral red shift in cell cultures (not shown). Both
characteristic changes seemed correlated with a vesicular production of
a fluorescent material not evident in the normal cells in vivo.
The third parameter tested was steady-state emission anisotropy of
the intrinsic fluorescence signal. Such a measurement is expected to
yield information about the amount of time the fluorophore has ro-
tated with respect to its fluorescence lifetime. For example, the rota-
tion time (and fluorescence lifetime) can change on NADH binding
to a high–molecular weight protein. Intrinsic fluorescence anisotropy
Figure 2. Standard histology and MPM/SHG of human ovarian ep-
ithelium and poorly differentiated adenocarcinoma. The same tis-
sue specimens were visualized after formalin fixation and paraffin
embedding followed by H&E staining (A and C) and before fixation
using MPM/SHG of intrinsic tissue emissions (B and D). (A, B) Mor-
phologically normal ovarian epithelium in the invaginations (arrow)
and simple cysts (arrowhead) near the surface of the ovary. (C–D)
Atypical neoplastic cells forming glandular structure (arrow) within
desmoplastic stroma (arrowhead). Note presence of collagen fibrils
imaged via second harmonic generation (SHG; blue), a feature not
readily evident in conventionally prepared tissue. MPM/SHG images
are acquired as in Figure 1. Scale bar, 30 μm in all images.
Figure 3. Ovarian surface epithelium carcinogenesis associated with conditional inactivation of p53 and Rb genes. Multilayered atypical
cells forming papillary structures (arrows) can be identified by conventional microscopy (A) and MPM/SHG (B). Thickening of the col-
lagen fibrils (arrowheads) near and at the basement membrane of early dysplastic lesion (arrow) is evident in the MPM/SHG image (C)
with the SHG reproduced in grayscale for clarity (D). (E) Expression of eGFP in the OSE of a mouse ovary after a single ovarian intrabursal
injection with 5 × 107 pfu/μl of AdCMVEGFP. Arrow indicates OSE; CL, corpus luteum; F , follicle; V , vessel. Green pseudocolor is GFP
fluorescence and yellow is intrinsic fluorescence (<500 nm emission). (F) Morphometric evaluation of intrinsic emission images of
mouse OSE. Size of individual cells and their nuclei and cytoplasm was assessed by estimation of area (white rings, μm2, mean ±
SE). (G) Results are plotted for images collected at 8 days after intrabursal administration of AdCMVCre (Cre) or AdCMVLacZ (LacZ)
to p53floxPRb1floxP mice. Unpaired t test yielded 2-tailed P = .0002 for whole-cell Cre versus LacZ (171.4 ± 12.4, n = 45 vs 120.4 ±
6.0, n = 53), P = .0466 for nucleus Cre versus LacZ (74.8 ± 5.3, n = 45 vs 53.0 ± 10.7, n = 26), and P = .0009 for cytoplasm Cre versus
LacZ (96.58 ± 8.7, n = 45 vs 65.6 ± 3.78, n = 53). (H) At 34 days after transformation, unpaired t test yielded 2-tailed P = .0007 for whole-
cell Cre versus LacZ (130.4 ± 6.5, n= 40 vs 92.1 ± 8.8, n= 36), P= .015 for nucleus Cre versus LacZ (70.0 ± 4.5, n= 40 vs 53.4 ± 4.9, n=
36), and P = .0007 for cytoplasm Cre versus LacZ (60.38 ± 4.3, n = 40 vs 38.6 ± 4.3, n = 36). All experiments have been performed in
duplicates, and yielded similar results. Scale bars, 15 μm (A, B), 20 μm (C, D), 30 μm (E), and 12 μm (F).
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in neoplastic OSE cells (0.301 ± 0.001, mean ± SE, n = 25 images)
was significantly (P < .0001) lower than that found in normal OSE
cells (0.319 ± 0.003 mean ± SE, n = 25 images). These results may
indicate that more metabolically active cells, such as neoplastic cells,
have a higher fraction of free to bound NAD(P)H (as has been
shown in transformed mammary cell cultures [32]).
However, in mice, we determined that intensity and anisotropy
values were highly sensitive to tissue scattering and thus depended
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on the amount and type of tissue through which the image was ob-
tained. Accordingly, intensity and anisotropy analyses of tissues have
yielded inconsistent results (not shown).
At the same time, a red shift in the average cellular intrinsic fluo-
rescence was reproducibly observed in tumor-derived cell masses
compared with normal OSE. MPM images of freshly excised tissue
from the disseminated metastasis model (Figure 4) exhibited an LW/
SW ratio that was significantly higher in neoplastic versus normal cells
(1.3 ± 0.1, mean ± SE, n = 7 tumors, vs 1.00 ± 0.03, n = 9 ovaries,
P = .0064). Intriguingly, the spectral shift in tumors appeared to arise
mainly from a separate population of red-emitting cells within the
tumor mass (Figure 4D). These red-emitting cells were found to
be viable by analysis of NADH intensity and costaining with the vital
stain calcein-AM (data not shown).
Intravital MPM of Ovarian Cancer Using Laparoscopic
Stick Objective
It has been previously demonstrated that under specific experimen-
tal conditions, usually in combination with research fluorophores,
MPM may be used for imaging in living animals (e.g., see Zipfel et al.
[9], Brown et al. [33], Condeelis and Segall [34]). To examine the
feasibility for in vivo applications without contrast agents, we imaged
ovaries from live mice (Figure 5, A–F ) by exteriorizing the ovary to
isolate it from the body cavity. This method was sufficient for resolv-
ing single OSE cells in unstained ovaries (Figure 5, A–C) and for dis-
criminating these normal OSE from early EOC neoplasias using the
floxed p53/Rb model (Figure 5, D–F ).
However, standard large-diameter microscope objectives preclude
access to internally located organs and tissues. In addition, to collect
images at micrometer-scale resolution, strategies for mitigating mo-
tion artifacts primarily because of patient breathing must be in place.
To address these challenges, we tested a microprobe “stick” objective
recently developed by Olympus. This series of optics are fully aberra-
tion corrected objective lenses with small-diameter (1.2 and 3.2 mm)
centimeter-long tips. We found simple GRIN lenses to be ineffective
for the collection of high-quality intrinsic emission images due pre-
sumably to their more significant aberrations. In agreement with our
previous results demonstrating the applicability of the Olympus
microprobe objective for MPM imaging of intrinsic fluorescence of
excised colon tissues [35], we could successfully image ovarian and
peritoneal tissues without staining (not shown). After additional im-
provements for tissue rinsing and stabilization by supplementary tub-
ing, we were able to image the parietal and visceral mesothelium and
underlying tissues of the peritoneal cavity. Importantly, neoplastic
cells were readily discernable from surrounding normal tissues in
the mouse model of disseminated peritoneal EOC (Figure 6).
Combination of Low-Magnification Screening with
High-Resolution MPM Optical Biopsy
A potential limitation of the stick objective lens is its small field of
view. To facilitate intravital screenings of neoplastic lesions across
large areas, mice were intraperitoneally injected with ProSense 680,
a complex that emits red light on cathepsin B–mediated hydrolysis.
In agreement with previous results [36], this indicator of protease
activity has been effective in the detection of neoplastic disseminated
peritoneal EOC cells by low magnification both with standard and
multiphoton excitation (Figure 7, A–D). Selected areas were subse-
quently visualized by the laparoscopic objective lens (Figure 7, E and
F ), enabling visualization of individual cells with cathepsin B activ-
ity. Whereas most fluorescent cells were neoplastic cells, capillaries
and intramuscular cells underneath of the parietal peritoneum (Fig-
ure 7G ) were also detected in agreement with earlier observations
[36]. MPM/SHG enabled a detailed mapping of the tumor boundary
in three dimensions, confirming our earlier observations that collagen
Figure 4. Emission color changes in intrinsic fluorescence of EOC.
Normal OSE (A and B) and neoplastic cells from the disseminated
peritoneal EOC model (C and D) were analyzed for the relative
amounts of LW/SW (510-650 nm/410-490 nm, green/red pseudo-
color) intrinsic fluorescence. For reference, SHG from the collagen
of the ovarian bursa is shown in blue pseudocolor. Intrinsic fluo-
rescence images of OSE are manually marked (green masked
areas, A and C). The white boxes mark the zoomed regions shown
in B and D, respectively. (E) Analysis of average pixel intensities in
the green masked areas shows that tumor intrinsic fluorescence is
red-shifted with respect to normal OSE owing to a distinct red-
emitting cell population (arrows, D). Average LW/SW ratios are
1.00 ± 0.03 (mean ± SE, n = 9; RU, relative units) for normal
OSE and 1.3 ± 0.1 (P = .0064, n = 7) for neoplasms. Data were
acquired from 450 images at 780-nm excitation. Scale bars, 50 μm
(A, C) and 25 μm (B, D).
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fibrils around tumors were straighter and orientated toward the tumor
boundary at the invasive front (Figure 7H ).
Discussion
Minimally invasive or noninvasive methods of cancer diagnosis and
therapeutic assessment in humans and real-time monitoring of carci-
nogenesis in experimental animals remain among the most coveted,
challenging goals of cancer research. Undoubtedly, such abilities would
tremendously facilitate our understanding of cancer initiation and
progression, as well as enable development of patient-tailored thera-
peutic approaches. Two recent developments have provided an exciting
premise for further studies. Firstly, there has been recent remarkable
progress in technologies, allowing noninvasive imaging of molecular
and cellular processes [37,38]. Secondly, technological progress in ma-
nipulating and genetically modifying the mouse genome has led to
rapidly expanded repertoire of accurate cancer models that genetically
and phenotypically mimic human cancers (reviewed in Jonkers and
Berns [39], Van Dyke and Jacks [40], and Frese and Tuveson [41]).
Both advances have stimulated the evolution of fluorescent con-
trast agents for detection and monitoring of cancer [37,42]. Problems
with these agents include reporter specificity, induced toxicity, and
appropriate delivery strategies. Endogenous emitters, in contrast, are
integral to the tissue. Although their photophysical characteristics are
generally inferior (dim and emitting at short wavelengths that scatter
easily in tissue), intrinsic tissue emissions exhibit signature properties
of the natural tissue [12]. Because emission spectra are independent of
the mode of excitation (i.e., conventional UV illumination vs two-
photon excitation), the interpretation of multiphoton intrinsic tissue
fluorescence images initially relies on a broad body of one-photon ex-
citation tissue spectroscopy and imaging experiments (for reviews, see
Ramanujam [10] and Richards-Kortum and Sevick-Muraca [11]), in
which significant effort has been dedicated toward identifying spec-
tral characteristics of intrinsic tissue that discriminate between normal
and dysplastic or neoplastic tissues. Generally, empirical diagnostic
criteria are established by analyzing the spectral shape of the intrinsic
fluorescence excitation and/or emission curves by using a training set
of cancerous versus normal specimens. This strategy has proven suc-
cessful for a wide variety of cancerous tissues [43–53] and has been
implemented in endoscopic devices for early detection of cancerous
lesions in cervix [51], colon [52], bladder [43], skin [44], oral cavity
[46,48,50], and esophagus [54]. Typically, spectral measurements are
taken at a single point in the tissue, the location of which is guided by
a white-light endoscope. Recently, however, imaging intrinsic fluores-
cence endoscopes have been developed (the LIFE-GI and Olympus
Figure 5. Discriminating normal from neoplastic OSE in live mice using MPM/SHG. Images of normal (A–C) and transformed (D–F) OSE
mice from the conditional inactivation of p53 and Rbmodel are acquired by exteriorizing the ovary and imaging with a standard objective
lens. In zoomed images from A and D, respectively, OSE (arrows) are resolvable as a single layer in normal ovaries (B) and in multiple
layers in neoplasia (E). In addition, the SHG channel (C, F) shows that the collagenous layer underneath of the OSE is visibly thicker
in the neoplasia (arrowhead). OB marks the ovarian bursa and >> marks horizontal motion artifacts due to mouse breathing. Scale bars,
30 μm (A, D) and 15 μm (B, C, E, and F).
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Auto-Fluorescence Videoscope systems) that show diagnostic poten-
tial for gastric [55], lung [56], and colon [57] cancers.
Albeit useful, the resolution of these systems is in the millimeter
range, precluding detection and characterization of microscopic le-
sions as well as evaluation of tissue properties at the single-cell level.
Nonlinear imaging approaches, such as MPM and SHG, have the
potential to address this current limitation [9]. However, their ap-
plicability to clinical settings greatly depends on several advances in-
cluding 1) the development of diagnostic criteria comparable to those
obtained from routine histologic imaging, 2) the ability to obtain
clear images in a difficult environment with significant optical scat-
tering from blood [58] and motion artifacts from breathing and heart
beat, 3) the development of endoscopic instruments compatible with
ultrafast optics, enabling minimally invasive access to target organs
and tissues, with high enough sensitivity to collect weak intrinsic
fluorescence signals, and 4) improvements in the ability to locate re-
gions for high-resolution assessment by MPM/SHG (better integra-
tion of the low- to high-magnification switch).
MPM/SHG Diagnostic Criteria
In the present study, we have tested the feasibility of MPM/SHG
imaging in ovarian cancer, where the need for early diagnosis and
thorough assessment of effectiveness of debulking surgery is of par-
ticular importance. Because the translation of new diagnostic tests
and approaches into clinical practice, and particularly into pathol-
ogy, greatly depends on the ability for linking new diagnostic crite-
ria with already established and clinically proven sets of features, we
have focused on advantages and disadvantages of imaging of na-
tive tissues with MPM compared with routine microscopy of H&E
histologic slides. Side-by-side evaluation of EOC specimens from hu-
man patients and mouse models has demonstrated that MPM/SHG
was sufficient to detect features of neoplasia such as size and shape
of cellular compartments and tissue architecture. In addition, MPM/
SHG images of tissue emissions provided information that was dif-
ferent to that obtained using standard histologic protocols. For in-
stance, SHG clearly delineates fibrillar collagen structure, which is
not visible in standard H&E sections. However, absent in MPM/
SHG images were diagnostic nuclear information such as nucleoli
size and shape, chromatin condensation, and localization. Further-
more, H&E color variations are also absent; cytosolic spaces are
instead largely delineated by NAD(P)H fluorescence, which is sensitive
to redox state [59].
The origins of many reproducible fluorescent features in the in-
trinsic tissue fluorescence images are still unknown. Our work con-
tributes to the development of an atlas or database for interpreting
intrinsic tissue emission changes characteristic of different lesions.
Such efforts complement those by other laboratories [14,35,60–63].
In addition to the direct applicability of MPM/SHG imaging for
diagnosis of neoplasia according to established pathological criteria,
several of its intrinsic features are particularly attractive for facilitation
of diagnosis. Firstly, MPM/SHG imaging allows rapid and three-
dimensional pathological assessment of excised tissue with virtually
no tissue preparation. This methodology should be useful in clini-
cal situations requiring fast three-dimensional images of biopsies or
in live tissue studies where tissue fixation cannot be used because
it perturbs the tissue architecture or processes under study. We dem-
onstrate here that MPM/SHG “optical sections” allow us to avoid
time-consuming serial histologic sectioning required for the accurate
evaluation of a single-layered OSE. It is anticipated that further stud-
ies using this approach will simplify morphometric assessments of
early ovarian lesions in humans.
Figure 6. Intravital MPM/SHG imaging in the abdominal cavity using a microprobe objective lens (diagram, A). Normal peritoneum (B and
C) and neoplastic cells of the disseminated peritoneal EOC model (D–G) imaged in vivo and in situ through an abdominal incision. Nor-
mal mesothelium is very thin, has low intrinsic fluorescence, and is essentially invisible using intravital MPM. However, neoplastic le-
sions are clearly visible at the invasive edge (D and E) and at the tumor surface (F and G). For clarity, SHG images are reproduced in
grayscale in C, E, and G. Motion artifacts due to mouse breathing are marked with >>. The yellow meniscus at the bottom of B is the
edge of field of view of the stick objective lens. Scale bar, 30 μm.
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Figure 7. Imaging cathepsin activity using MPM/SHG. Images of the normal peritoneum (A, C, E, and G) and peritoneal tumors (B, D, F and
H, arrows) from the disseminated peritoneal model after administration of ProSense 680 (red). Detection of neoplastic lesion using stan-
dard stereofluoroscopy (A and B) and subsequent mapping its tumor boundaries (D, arrowheads) in three dimensions with MPM/SHG. In
this case, normal (C) and tumor (D) images were collected with a low-magnification objective (4×/0.28 NA) and displayed as projections,
each from 100 images at 5-μm intervals. Discrimination between normal abdominal wall (E) and neoplasm (F) at cellular resolution with the
stick objective. High-resolution MPM/SHG images demonstrate cathepsin activity in certain stromal cells (G, arrowheads) and neoplastic
cells (H, arrow). In addition, they show alterations in the size and shape of neoplastic cells and tissue architecture as well as the orientation
of collagen fibrils toward tumor boundary (H, arrowhead). Scale bars, 1000 μm (A, B), 500 μm (C, D), 80 μm (E, F), and 100 μm (G, H).
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Secondly, MPM/SHG imaging allowed better estimation of loca-
tion and characterization of collagenous stroma. Because metastatic
progression of ovarian cancer is known to coincide with increased
collagen synthesis and degradation [26,64], we analyzed images for
an increase in segmental collagen associated with fibrillogenesis in the
regions surrounding tumors but found comparable amounts. Instead,
we observed a thickening of collagen at the basement membrane in
early ovarian neoplasias and straighter, less uniform collagen fibrils
around peritoneal neoplastic implants, consistent with previous re-
ports that stromal matrix components become rearranged in tight,
linearly aligned fibers in invasive ovarian carcinomas [65,66]. In ad-
dition, we demonstrated that most collagen fibers near the invasive
edge are located perpendicular toward its surface. These results are
consistent with previous reports from breast tumors [62], suggesting
that fibrils oriented perpendicular to the tumor were correlated to
tumor cell infiltration to the host stromal tissue.
Thirdly, MPM allows comprehensive evaluation of spectral changes
in intrinsic fluorescence with cellular resolution. We determined that
intensity and anisotropy analyses of tissues are unlikely to yield con-
sistent results owing to their high sensitivity to tissue scattering. Sim-
ilar to a previous report from human tissue [14], we detected a red
shift in fluorescence of neoplastic cells in mice with advanced EOC.
Kirkpatrick et al. [14] attributed this spectral shift to an increase in
the overall FAD-to-NAD(P)H ratio. However, according to our ob-
servations, this alteration in intrinsic cellular fluorescence derives not
from an average color change but from a specific population of redder-
emitting cells within the tumor. These cells were determined to be
alive by cellular NAD(P)H expression and calcein-AM staining and
may represent porphyrin-containing cells [47,67,68].
Toward an In Vivo Implementation of Intrinsic Tissue
Fluorescence MPM/SHG
Clearly, a standard multiphoton microscope cannot be used for
microscopic imaging in humans. However, several new technologic
advances have made an endoscopic version of MPM/SHG—a device
for in vivo collection of histologic-like images—to be a realistically
achievable goal. Several recently developed confocal endoscopes offer
remarkable cellular-scale imaging in vivo and are undergoing clinical
trials [69,70]. In these devices, motion artifacts are minimized with
catheter tissue stabilization and use of suction ports. An endoscopic
implementation of MPM may complement such efforts with the
additional ability for imaging intrinsic tissue fluorescence and an ex-
pected several-fold increase in depth penetration [9]. The first chal-
lenge has been to engineer fibers through which sufficiently powerful
femtosecond laser pulses can propagate with minimal temporal pulse
broadening due to dispersion. An uncompensated 1-nJ, 100-fs pulse
will lengthen to ∼4000 fs after traveling through a meter of optical
fiber (reducing the 2P excitation potential by a factor of 40). Pulse
dispersion can be partially compensated at low powers. However, for
higher power delivery, microstructured fibers are necessary. These are
relatively large (keeping average intensities low) but only propagate a
single mode because of the intricate boundary conditions [71,72].
Scanning is done either by wiggling the fiber [70,73–76] or through
MEM devices [77] transferred to a gradient-index or microlens for
focusing [78]. Several researchers have demonstrated collagen imag-
ing through an MPM endoscope [77,79] but not yet in vivo. The real
challenge has been to design an endoscope with the sensitivity for
imaging intrinsic cellular fluorophores, which are typically 100-fold
dimmer than standard fluorophores [12]. In the current study, we
demonstrate cellular visualization in vivo using MPM/SHG of intrin-
sic emissions that can be used to identify neoplasias in several mouse
models of ovarian cancer. In addition, we demonstrate the feasibility
of an in vivo laparoscopic implementation of MPM/SHG by using a
recently developed 3-mm-diameter stick objective that allows direct
access to imaged tissues. In this case, a separate small tube served to
stabilize and rinse the tissue, the latter capability being particularly
relevant to tumors that present with internal bleeding.
Contrast Agents for Targeting MPM/SHG to Putative
Neoplastic Lesions Regions
In addition to endogenous intrinsic fluorescence, it is likely that
fluorescent contrast agents (e.g., ALA [80]) and/or smart indicators
[42,81] will improve diagnostic information and signal once issues of
toxicity and delivery are better understood. Others have demonstrated
the utility of the cathepsin activity indicator ProSense 680 for ovar-
ian cancer diagnostics [7]. We showed that this signal can be used
to quickly identify lesions with standard fluoroscopy for subsequent
cellular-resolved interrogation using MPM/SHG. ProSense 680 can
be imaged simultaneously with intrinsic tissue emissions providing
a contextual tissue background. Because it fluoresces in the NIR,
ProSense 680 may also substantially improve the depth and accuracy
to which lesions can be mapped with MPM/SHG in the difficult
in vivo environment.
Taken together, our results demonstrate the feasibility of high-
resolution imaging of epithelial ovarian cancer by laparoscopic non-
linear microscopy. They also demonstrate the value of MPM/SHG
imaging for rapid initial assessment of ovarian cancer samples. Fur-
ther advances in photonics and microfabrication should make it pos-
sible to produce an efficient fiber-coupled multiphoton endoscope
with capabilities for a minimally invasive, all-optical biopsy for a cel-
lularly resolved diagnostic assessment of ovarian cancer lesions as well
as other malignancies.
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